https://gregory-ms.com/articles/314717/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_314717

Stem cell transplantation holds significant promise for regenerative medicine, but immune rejection remains a major obstacle. Recent advances leverage CRISPR/Cas9 to engineer hypoimmunogenic induced pluripotent stem cells. Future research priorities include integrating AI-based immune profiling, precision genome editing, and advanced 3D-bioprinting technologies.

#MultipleSclerosis #MSchat #MS #Neurology